Literature DB >> 23036152

SAR, cardiac myocytes protection activity and 3D-QSAR studies of salubrinal and its potent derivatives.

J Liu1, K-L He, X Li, R-J Li, C-L Liu, W Zhong, S Li.   

Abstract

Salubrinal is a selective inhibitor of endoplasmic reticulum (ER) stress and affords remarkable protection to cardiomyocytes. By studying the structure-activity relationship (SAR) of salubrinal, it was found that modification of the quinoline ring terminus and thiourea unit could confer the compound PP1-24 with markedly enhanced cardioprotective activity (EC50 ≤ 0.3 μM) that is 50-fold more potent than salubrinal. Comparative molecular field analysis (CoMFA) was performed using the obtained biological data and resulted in a statistically significant CoMFA model with high predictive power (q2 = 0.741, r2 = 0.991).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23036152

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  4 in total

1.  Genome-wide analysis of tunicamycin-induced endoplasmic reticulum stress response and the protective effect of endoplasmic reticulum inhibitors in neonatal rat cardiomyocytes.

Authors:  Chun-Lei Liu; Wu Zhong; Yun-Yun He; Xin Li; Song Li; Kun-Lun He
Journal:  Mol Cell Biochem       Date:  2016-01-06       Impact factor: 3.396

Review 2.  Turn and Face the Strange: A New View on Phosphatases.

Authors:  Maja Köhn
Journal:  ACS Cent Sci       Date:  2020-03-13       Impact factor: 14.553

3.  Molecular docking studies of salubrinal and its analogs as inhibitors of the GADD34:PP1 enzyme.

Authors:  Pavlo V Zadorozhnii; Ihor O Pokotylo; Vadym V Kiselev; Oxana V Okhtina; Aleksandr V Kharchenko
Journal:  ADMET DMPK       Date:  2019-04-05

4.  Inhibition of serine/threonine protein phosphatase PP1 protects cardiomyocytes from tunicamycin-induced apoptosis and I/R through the upregulation of p-eIF2α.

Authors:  Chun-Lei Liu; Yun-Yun He; Xin Li; Rui-Jun Li; Kun-Lun He; Li-Li Wang
Journal:  Int J Mol Med       Date:  2013-12-23       Impact factor: 4.101

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.